Nephrology Times

06/16/2026

Catch up on highlights on our website.
https://buff.ly/m6MnrSs

Review key research highlights from the 63rd ERA Congress featuring major study readouts, emerging data in kidney disease, and expert insights shaping clinical practice.

06/10/2026

🔗 https://buff.ly/J2G4eWY
We asked 4 nephrologists: How do you foster strong communication within a multidisciplinary care team?

In this recurring Nephrology Times feature, we asked four nephrologists: How do you foster strong communication within a multidisciplinary care team?

06/04/2026

🔗 https://buff.ly/xynXWNh
DON'T MISS our June cover story about the effects of rising temperatures on kidney health.

As temperatures rise due to climate change, so do heat-related kidney illnesses, including acute kidney injury (AKI) and chronic kidney disease (CKD).

06/01/2026

🔗 https://buff.ly/0FJW8Ql
New month, new issue! Read the June edition of Nephrology Times, featuring heat's effects on kidney health, depression in CKD, research highlights, and more.

05/29/2026

🔗 https://buff.ly/I0mTtRW
Nurse educator Dr. Jami S. Brown explores the prevalence of depression in CKD and why mental health should be part of CKD care.

Nurse educator Jami S. Brown explores the prevalence of depression in chronic kidney disease and why mental health assessment should be part of CKD care.

05/28/2026

🔗 https://buff.ly/yazOR9r
Finerenone, already approved for adults with CKD associated with type 2 diabetes, has been granted Priority Review by the FDA for adults with CKD and type 1 diabetes.

The FDA has granted Priority Review to finerenone for the treatment of adults with type 1 diabetes and chronic kidney disease (CKD).

05/26/2026

🔗 https://www.docwirenews.com/post/the-case-for-good-enough-kidneys-in-older-adults
Anna Gaddy, MD, shares her thoughts on Matthew Kaufman's recent study showing that transplanting less than perfect kidneys has clinical and cost benefits for older adults.

Anna Gaddy, MD, discusses recent study findings from Matthew Kaufmann, PhD, showing that transplantation with kidneys of decreased quality may be worthwhile for older adults.

05/16/2026

🗞️ Play catch-up this weekend. Did you know our print issues are available to read on our website?
🔗 https://buff.ly/KrTFrMD

05/15/2026

🔗 https://www.docwirenews.com/post/insights-on-duplex-and-the-importance-of-proteinuria
We captured so many great interviews with Joel Topf, MD, at . Check out his chat with Kenneth Lieberman, MD, coauthor of an abstract on the DUPLEX trial of in , showing the drug's reduction effects occurred regardless of baseline.

Kenneth Lieberman, MD, speaks to Joel Topf, MD, about DUPLEX, a trial of sparsentan in FSGS, and the importance of proteinuria in kidney trials.